Skip to main content
Clinical Trials/ACTRN12611000149965
ACTRN12611000149965
Recruiting
未知

Feasibility of use of acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer

Royal Prince Alfred Hospital0 sites30 target enrollmentFebruary 8, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Arthralgia secondary to aromatase inhibitor
Sponsor
Royal Prince Alfred Hospital
Enrollment
30
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Early breast cancer patients taking thrid generaion aromatase inhibitor.
  • Women with ongoing pain and/or stiffness in one or more joints which worsened after starting aromatase inhibitor.
  • Baseline worst pain score on BPI\-SF of 3 or greater (scale 0\-10\)

Exclusion Criteria

  • Previous use of acupuncture for Aromatase Inhibitor induced joint paint
  • Severe concomitant illness or metastatic breast cancer
  • Severe coagulopathy or bleeding disorder or dermatological disease within the acupuncture area (including patients on warfarin or low molecular weight heparin).
  • Patients with cardiac pacemakers, defibrilator or any other implanted or topical electrical device.
  • Needle phobia rendering a patient unable to receive acupuncture.
  • Patients with intellectual or mental impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials